Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
11.36
-0.74 (-6.16%)
Oct 8, 2026, 10:58 AM EDT - Market open
Turn Therapeutics Employees
Turn Therapeutics had 2 employees as of December 31, 2025. The number of employees decreased by 2 or -50.00% compared to the previous year. That makes Turn Therapeutics the 43,505th largest employer in the world and 7,253rd in the United States.
Employees
2
Change
-2
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$4,222,987
Market Cap
338.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | - | - | 2 | 0 |
| Jun 30, 2025 | 2 | -2 | -50.00% | 2 | 0 |
| Jun 30, 2024 | 4 | - | - | 1 | 3 |
| Dec 31, 2023 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Enanta Pharmaceuticals | 120 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Orchestra BioMed Holdings | 86 |
| Agenus | 81 |
| Zura Bio | 40 |
| Fennec Pharmaceuticals | 35 |
| Opus Genetics | 28 |
TTRX News
- 14 days ago - Turn Therapeutics initiated with a Buy at Lucid Capital - TheFly
- 14 days ago - Turn Therapeutics Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 4 weeks ago - Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Business Wire
- 4 weeks ago - Turn Therapeutics appoints Redfield as Chief Scientific Officer - TheFly
- 4 weeks ago - Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D. - Business Wire
- 7 weeks ago - Turn Therapeutics announces publication of peer-reviewed research on GX-03 - TheFly
- 7 weeks ago - Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch - Business Wire
- 7 weeks ago - Turn Therapeutics reports Q2 EPS (20c) vs (5c) last year - TheFly